United States Pediatric Drugs and Vaccines Market Report 2018

January 2018 | 114 pages | ID: U5FB442EB84EN
QYResearch

Abstracts

In this report, the United States Pediatric Drugs and Vaccines market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pediatric Drugs and Vaccines in these regions, from 2013 to 2025 (forecast).

United States Pediatric Drugs and Vaccines market competition by top manufacturers/players, with Pediatric Drugs and Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck & Co., Inc. (USA)
• Abbott Laboratories (USA)
• Amgen, Inc. (USA)
• Eli Lilly and Company (USA)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Genentech, Inc. (USA)
• GlaxoSmithKline plc. (UK)
• Janssen Biologics B.V. (USA)
• Actelion Pharmaceuticals
• AstraZeneca Plc. (UK)
• Boehringer Ingelheim GmbH (Germany)
• Bristol-Myers Squibb Company (USA)
• Allergan, Inc. (USA)
• Novartis AG (Switzerland)
• Novo Nordisk A/S (Denmark)
• Pfizer, Inc. (USA)
• Sanofi S.A (France)
• Shionogi Inc. (USA)
• Shire Pharmaceuticals Group Plc. (UK)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• by Vaccine Types
• Diphtheria
• Influenza
• Hepatitis
• Pneumococcal Diseases
• Meningococcal Diseases
• Mumps
• Others
• by Disease Types
• Roseola
• Tetanus
• Whooping Cough
• Allergy and Respiratory Diseases
• Malaria
• Anemia
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Newborn
• Infant
• Child

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pediatric Drugs and Vaccines Market Report 2018

1 PEDIATRIC DRUGS AND VACCINES OVERVIEW

1.1 Product Overview and Scope of Pediatric Drugs and Vaccines
1.2 Classification of Pediatric Drugs and Vaccines by Product Category
  1.2.1 United States Pediatric Drugs and Vaccines Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Pediatric Drugs and Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Diphtheria
  1.2.4 Influenza
  1.2.5 Hepatitis
  1.2.6 Pneumococcal Diseases
  1.2.7 Meningococcal Diseases
  1.2.8 Mumps
  1.2.9 Others
1.3 United States Pediatric Drugs and Vaccines Market by Application/End Users
  1.3.1 United States Pediatric Drugs and Vaccines Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Newborn
  1.3.3 Infant
  1.3.4 Child
1.4 United States Pediatric Drugs and Vaccines Market by Region
  1.4.1 United States Pediatric Drugs and Vaccines Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Pediatric Drugs and Vaccines Status and Prospect (2013-2025)
  1.4.3 Southwest Pediatric Drugs and Vaccines Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Pediatric Drugs and Vaccines Status and Prospect (2013-2025)
  1.4.5 New England Pediatric Drugs and Vaccines Status and Prospect (2013-2025)
  1.4.6 The South Pediatric Drugs and Vaccines Status and Prospect (2013-2025)
  1.4.7 The Midwest Pediatric Drugs and Vaccines Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Pediatric Drugs and Vaccines (2013-2025)
  1.5.1 United States Pediatric Drugs and Vaccines Sales and Growth Rate (2013-2025)
  1.5.2 United States Pediatric Drugs and Vaccines Revenue and Growth Rate (2013-2025)

2 UNITED STATES PEDIATRIC DRUGS AND VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pediatric Drugs and Vaccines Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Pediatric Drugs and Vaccines Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Pediatric Drugs and Vaccines Average Price by Players/Suppliers (2013-2018)
2.4 United States Pediatric Drugs and Vaccines Market Competitive Situation and Trends
  2.4.1 United States Pediatric Drugs and Vaccines Market Concentration Rate
  2.4.2 United States Pediatric Drugs and Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pediatric Drugs and Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PEDIATRIC DRUGS AND VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Pediatric Drugs and Vaccines Sales and Market Share by Region (2013-2018)
3.2 United States Pediatric Drugs and Vaccines Revenue and Market Share by Region (2013-2018)
3.3 United States Pediatric Drugs and Vaccines Price by Region (2013-2018)

4 UNITED STATES PEDIATRIC DRUGS AND VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Pediatric Drugs and Vaccines Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Pediatric Drugs and Vaccines Revenue and Market Share by Type (2013-2018)
4.3 United States Pediatric Drugs and Vaccines Price by Type (2013-2018)
4.4 United States Pediatric Drugs and Vaccines Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PEDIATRIC DRUGS AND VACCINES SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Pediatric Drugs and Vaccines Sales and Market Share by Application (2013-2018)
5.2 United States Pediatric Drugs and Vaccines Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PEDIATRIC DRUGS AND VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck & Co., Inc. (USA)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories (USA)
  6.2.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Amgen, Inc. (USA)
  6.3.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly and Company (USA)
  6.4.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche Ltd (Switzerland)
  6.5.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Genentech, Inc. (USA)
  6.6.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline plc. (UK)
  6.7.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Janssen Biologics B.V. (USA)
  6.8.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Actelion Pharmaceuticals
  6.9.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca Plc. (UK)
  6.10.2 Pediatric Drugs and Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim GmbH (Germany)
6.12 Bristol-Myers Squibb Company (USA)
6.13 Allergan, Inc. (USA)
6.14 Novartis AG (Switzerland)
6.15 Novo Nordisk A/S (Denmark)
6.16 Pfizer, Inc. (USA)
6.17 Sanofi S.A (France)
6.18 Shionogi Inc. (USA)
6.19 Shire Pharmaceuticals Group Plc. (UK)

7 PEDIATRIC DRUGS AND VACCINES MANUFACTURING COST ANALYSIS

7.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pediatric Drugs and Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pediatric Drugs and Vaccines Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PEDIATRIC DRUGS AND VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Pediatric Drugs and Vaccines Sales Volume Forecast by Type (2018-2025)
11.3 United States Pediatric Drugs and Vaccines Sales Volume Forecast by Application (2018-2025)
11.4 United States Pediatric Drugs and Vaccines Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pediatric Drugs and Vaccines
Figure United States Pediatric Drugs and Vaccines Market Size (K Units) by Type (2013-2025)
Figure United States Pediatric Drugs and Vaccines Sales Volume Market Share by Type (Product Category) in 2017
Figure Diphtheria Product Picture
Figure Influenza Product Picture
Figure Hepatitis Product Picture
Figure Pneumococcal Diseases Product Picture
Figure Meningococcal Diseases Product Picture
Figure Mumps Product Picture
Figure Others Product Picture
Figure United States Pediatric Drugs and Vaccines Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Pediatric Drugs and Vaccines by Application in 2017
Figure Newborn Examples
Table Key Downstream Customer in Newborn
Figure Infant Examples
Table Key Downstream Customer in Infant
Figure Child Examples
Table Key Downstream Customer in Child
Figure United States Pediatric Drugs and Vaccines Market Size (Million USD) by Region (2013-2025)
Figure The West Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2013-2025)
Figure United States Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Pediatric Drugs and Vaccines Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Pediatric Drugs and Vaccines Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Pediatric Drugs and Vaccines Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Pediatric Drugs and Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Pediatric Drugs and Vaccines Sales Share by Players/Suppliers
Figure United States Pediatric Drugs and Vaccines Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Pediatric Drugs and Vaccines Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Pediatric Drugs and Vaccines Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Pediatric Drugs and Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Pediatric Drugs and Vaccines Revenue Share by Players/Suppliers
Table United States Market Pediatric Drugs and Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Pediatric Drugs and Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Pediatric Drugs and Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Pediatric Drugs and Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pediatric Drugs and Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pediatric Drugs and Vaccines Product Category
Table United States Pediatric Drugs and Vaccines Sales (K Units) by Region (2013-2018)
Table United States Pediatric Drugs and Vaccines Sales Share by Region (2013-2018)
Figure United States Pediatric Drugs and Vaccines Sales Share by Region (2013-2018)
Figure United States Pediatric Drugs and Vaccines Sales Market Share by Region in 2017
Table United States Pediatric Drugs and Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Pediatric Drugs and Vaccines Revenue Share by Region (2013-2018)
Figure United States Pediatric Drugs and Vaccines Revenue Market Share by Region (2013-2018)
Figure United States Pediatric Drugs and Vaccines Revenue Market Share by Region in 2017
Table United States Pediatric Drugs and Vaccines Price (USD/Unit) by Region (2013-2018)
Table United States Pediatric Drugs and Vaccines Sales (K Units) by Type (2013-2018)
Table United States Pediatric Drugs and Vaccines Sales Share by Type (2013-2018)
Figure United States Pediatric Drugs and Vaccines Sales Share by Type (2013-2018)
Figure United States Pediatric Drugs and Vaccines Sales Market Share by Type in 2017
Table United States Pediatric Drugs and Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Pediatric Drugs and Vaccines Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Pediatric Drugs and Vaccines by Type (2013-2018)
Figure Revenue Market Share of Pediatric Drugs and Vaccines by Type in 2017
Table United States Pediatric Drugs and Vaccines Price (USD/Unit) by Types (2013-2018)
Figure United States Pediatric Drugs and Vaccines Sales Growth Rate by Type (2013-2018)
Table United States Pediatric Drugs and Vaccines Sales (K Units) by Application (2013-2018)
Table United States Pediatric Drugs and Vaccines Sales Market Share by Application (2013-2018)
Figure United States Pediatric Drugs and Vaccines Sales Market Share by Application (2013-2018)
Figure United States Pediatric Drugs and Vaccines Sales Market Share by Application in 2017
Table United States Pediatric Drugs and Vaccines Sales Growth Rate by Application (2013-2018)
Figure United States Pediatric Drugs and Vaccines Sales Growth Rate by Application (2013-2018)
Table Merck & Co., Inc. (USA) Basic Information List
Table Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure Abbott Laboratories (USA) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table Amgen, Inc. (USA) Basic Information List
Table Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure Amgen, Inc. (USA) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company (USA) Basic Information List
Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table F. Hoffmann-La Roche Ltd (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table Genentech, Inc. (USA) Basic Information List
Table Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure Genentech, Inc. (USA) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline plc. (UK) Basic Information List
Table GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table Janssen Biologics B.V. (USA) Basic Information List
Table Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure Actelion Pharmaceuticals Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales Growth Rate (2013-2018)
Figure AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales Market Share in United States (2013-2018)
Figure AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Allergan, Inc. (USA) Basic Information List
Table Novartis AG (Switzerland) Basic Information List
Table Novo Nordisk A/S (Denmark) Basic Information List
Table Pfizer, Inc. (USA) Basic Information List
Table Sanofi S.A (France) Basic Information List
Table Shionogi Inc. (USA) Basic Information List
Table Shire Pharmaceuticals Group Plc. (UK) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pediatric Drugs and Vaccines
Figure Manufacturing Process Analysis of Pediatric Drugs and Vaccines
Figure Pediatric Drugs and Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Pediatric Drugs and Vaccines Major Players/Suppliers in 2017
Table Major Buyers of Pediatric Drugs and Vaccines
Table Distributors/Traders List
Figure United States Pediatric Drugs and Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Pediatric Drugs and Vaccines Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Pediatric Drugs and Vaccines Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Pediatric Drugs and Vaccines Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Pediatric Drugs and Vaccines Sales Volume (K Units) Forecast by Type in 2025
Table United States Pediatric Drugs and Vaccines Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Pediatric Drugs and Vaccines Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Pediatric Drugs and Vaccines Sales Volume (K Units) Forecast by Application in 2025
Table United States Pediatric Drugs and Vaccines Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Pediatric Drugs and Vaccines Sales Volume Share Forecast by Region (2018-2025)
Figure United States Pediatric Drugs and Vaccines Sales Volume Share Forecast by Region (2018-2025)
Figure United States Pediatric Drugs and Vaccines Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources